Description

To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline

Guest: Atta Behfar, M.D., Ph.D. (@AttaBehfar)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Traditional treatment of cardiac disease, especially advanced congestive heart failure has been limited. Transplantation has potential for benefit; however, organ shortage remains a barrier. It’s anticipated that regenerative medicine will help solve this unmet need with new treatment options to repair damaged heart tissue. This podcast will discuss regenerative medicine for cardiovascular disease with Dr. Atta Behfar, a Mayo Clinic cardiologist with expertise in advanced heart failure and transplantation. We’ll review the progress made in regenerative medicine in management of cardiovascular disease, what treatment options are currently available and the potential treatment options which will become available in the future.

Specific topics discussed:

• Regenerative potential of the cardiovascular system
• Current challenges in management of patients with cardiovascular disease
• Progress in regenerative medicine for the cardiovascular system
• Limitations in regenerative cardiac therapy using regenerative medicine
• Future potential for regenerative medicine treatment of cardiovascular disease
• Patients who are candidates for cardiac regenerative therapies

 Additional resources:

• Clinical Trials available at Mayo Clinic through the Center for Regenerative Medicine: https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials
• U.S. National Library of Medicine: https://www.clinicaltrials.gov/
• Center Watch: https://www.centerwatch.com/

 Additional educational opportunities from Mayo Clinic:

• https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
• https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.